Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Cash from Operations (2021 - 2025)

Historic Cash from Operations for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to -$2.3 million.

  • HeartSciences' Cash from Operations fell 690.23% to -$2.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$7.5 million, marking a year-over-year increase of 484.32%. This contributed to the annual value of -$7.4 million for FY2025, which is 2212.14% down from last year.
  • As of Q4 2025, HeartSciences' Cash from Operations stood at -$2.3 million, which was down 690.23% from -$2.0 million recorded in Q3 2025.
  • HeartSciences' 5-year Cash from Operations high stood at -$717491.0 for Q3 2021, and its period low was -$2.3 million during Q4 2025.
  • Its 5-year average for Cash from Operations is -$1.5 million, with a median of -$1.6 million in 2024.
  • Its Cash from Operations has fluctuated over the past 5 years, first crashed by 15250.6% in 2022, then soared by 2288.88% in 2025.
  • Over the past 5 years, HeartSciences' Cash from Operations (Quarter) stood at -$768053.0 in 2021, then plummeted by 40.63% to -$1.1 million in 2022, then grew by 8.51% to -$988187.0 in 2023, then crashed by 120.97% to -$2.2 million in 2024, then dropped by 6.9% to -$2.3 million in 2025.
  • Its Cash from Operations was -$2.3 million in Q4 2025, compared to -$2.0 million in Q3 2025 and -$1.6 million in Q2 2025.